Arrowstreet Capital, Limited Partnership Dr Reddys Laboratories LTD Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 46,552 shares of RDY stock, worth $687,573. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,552
Previous 104,951
55.64%
Holding current value
$687,573
Previous $7.7 Million
53.92%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding RDY
# of Institutions
238Shares Held
24.2MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$30.5 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$30.4 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$30 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2MShares$29.5 Million0.27% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$26.6 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.45B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...